StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$947.52−3.43 (-0.36%)

Close on Nov 17, 2026Market cap –P/E 48.4Yield –

argenx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was $35.53M, up 254.4% from the year before. The highest annual figure on record is $497.28M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$35.53M+254.4%
FY2022Dec 31, 2022$10.03M-98.0%
FY2021Dec 31, 2021$497.28M+1105.7%
FY2020Dec 31, 2020$41.24M-47.4%
FY2019Dec 31, 2019$78.46M+265.2%
FY2018Dec 31, 2018$21.48M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2022Jun 30, 2022$96.00M–

More argenx figures

See a number that looks wrong?